Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - dapagliflozin
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp47e609a7556335e73540caeda7f501b2
identifier: http://ema.europa.eu/identifier
/EU/1/23/1721/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Dapagliflozin Viatris 5 mg film-coated tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-47e609a7556335e73540caeda7f501b2
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/23/1721/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - dapagliflozin
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
What Dapagliflozin Viatris is
Dapagliflozin Viatris contains the active substance dapagliflozin. It belongs to a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors . They work by blocking the SGLT2 protein in your kidney. By blocking this protein, blood sugar (glucose), salt (sodium) and water are removed from your body via the urine.
What Dapagliflozin Viatris is used for
Dapagliflozin Viatris is used to treat:
What is type 2 diabetes and how does Dapagliflozin Viatris help?
What is heart failure and how does Dapagliflozin Viatris help?
What is chronic kidney disease and how does Dapagliflozin Viatris help?
Do not take Dapagliflozin Viatris
Warnings and precautions
Contact a doctor or the nearest hospital straight away:
Diabetic ketoacidosis
If you suspect you have diabetic ketoacidosis, contact a doctor or the nearest hospital straight away and do not take this medicine.
Necrotising fasciitis of the perineum
Talk to your doctor, pharmacist or nurse before taking Dapagliflozin Viatris:
If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Dapagliflozin Viatris.
Diabetes and foot care
If you have diabetes, it is important to check your feet regularly and adhere to any other advice regarding foot care given by your health care professional.
Urine glucose
Because of how Dapagliflozin Viatris works, your urine will test positive for sugar while you are on this medicine.
Children and adolescents
Dapagliflozin Viatris can be used in children aged 10 years and older for the treatment of type 2 diabetes. No data are available in children below 10 years of age.
Dapagliflozin Viatris is not recommended for children and adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, because it has not been studied in these patients.
Other medicines and Dapagliflozin Viatris
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Especially tell your doctor:
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should stop taking this medicine if you become pregnant, since it is not recommended during the second and third trimesters of pregnancy. Talk to your doctor about the best way to control your blood sugar while you are pregnant.
Talk to your doctor if you would like to or are breast-feeding before taking this medicine. Do not use Dapagliflozin Viatris if you are breast-feeding. It is not known if this medicine passes into human breast milk.
Driving and using machines
Dapagliflozin Viatris has no or negligible influence on the ability to drive and use machines.
Taking this medicine with other medicines called sulphonylureas or with insulin can cause too low blood sugar levels (hypoglycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines.
Do not drive or use any tools or machines, if you feel dizzy taking Dapagliflozin Viatris.
Dapagliflozin Viatris contains lactose
Dapagliflozin Viatris contains lactose (milk sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Dapagliflozin Viatris contains sodium.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially sodium- free .
Always take this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
How much to take
Taking this medicine
Your doctor may prescribe Dapagliflozin Viatris together with other medicine(s). Remember to take these other medicine(s) as your doctor has told you. This will help get the best results for your health.
Diet and exercise can help your body use its blood sugar better. If you have diabetes, it is important to stay on any diet and exercise program recommended by your doctor while taking Dapagliflozin Viatris.
If you take more Dapagliflozin Viatris than you should
If you take more Dapagliflozin Viatris tablets than you should, talk to a doctor or go to a hospital immediately.
Take the medicine pack with you.
If you forget to take Dapagliflozin Viatris
What to do if you forget to take a tablet depends on how long it is until your next dose.
If you stop taking Dapagliflozin Viatris
Do not stop taking Dapagliflozin Viatris without talking to your doctor first. If you have diabetes, your blood sugar may increase without this medicine.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact a doctor or the nearest hospital straight away if you have any of the following side effects:
This may occur regardless of blood sugar level. Your doctor may decide to temporarily or permanently stop your treatment with Dapagliflozin Viatris.
Stop taking Dapagliflozin Viatris and see a doctor as soon as possible if you notice any of the following serious side effects:
Although uncommon, if you see blood in your urine, tell your doctor immediately.
Contact your doctor as soon as possible if you have any of the following side effects:
Your doctor will tell you how to treat low blood sugar levels and what to do if you get any of the signs above.
Other side effects when taking Dapagliflozin Viatris:
Common
Uncommon (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 10 000 people)
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacis or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP . The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Dapagliflozin Viatris contains
What Dapagliflozin Viatris looks like and contents of the pack
Dapagliflozin Viatris 5 mg film-coated tablets are yellow coloured, round shaped, biconvex film- coated tablet with diameter of approximetely 7.24 mm. Debossed with 5 on one side and plain on the other side.
Dapagliflozin Viatris 10 mg film-coated tablets are yellow coloured, diamond shaped, biconvex with dimensions of approximately 11 x 8 mm. Debossed with 10 on one side and plain on the other side.
Dapagliflozin Viatris 5 mg tablets are available in: Aluminium blisters in pack sizes of 14, 28, 30 or 98 film-coated tablets. Calendar blisters of 28 or 98 film-coated tablets Perforated unit dose blisters of 14 x 1, 28 x 1, 30 x 1 or 98 x 1 film-coated tablets Bottles in pack sizes of 30 or 90 film-coated tablets.
Dapagliflozin Viatris 10 mg tablets are available in: Aluminium blisters in pack sizes of 14, 28, 30 or 98 film-coated tablets. Calendar blisters of 28 or 98 film-coated tablets Perforated unit dose blisters of 14 x 1, 28 x 1, 30 x 1 or 98 x 1 film-coated tablets Bottles in pack sizes of 30 or 90 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Viatris Limited Damastown Industrial Park Mulhuddart Dublin DUBLIN Ireland
Name and address of the manufacturer responsible for batch release
Mylan Hungary Kft Mylan Utca 1 Kom rom, 2900, Hungary
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Belgi /Belgique/Belgien Mylan bvba/sprl T l/Tel: + 32 (0)2 658 61 Lietuva Mylan Healthcare UAB Tel: +370 5 205 1
: +359 2 44 55 Luxembourg/Luxemburg Mylan bvba/sprl Tel: + 32 (0)2 658 61 (Belgique/Belgien)
esk republika Mylan Healthcare CZ s.r.o. Tel: +420 222 004 Magyarorsz g Mylan EPD Kft Tel: + 36 1 465 2Danmark Viatris ApS Tlf: +45 28 11 69 Malta V.J. Salomone Pharma Ltd Tel: + 356 21 22 01 Deutschland Mylan Healthcare GmbH Tel: +49 800 0700 Nederland Mylan BV Tel: +31 (0)20 426 3Eesti BGP Products Switzerland GmbH Eesti filiaal Tel: + 372 6363 Norge Mylan Healthcare Norge AS Tel: + 47 66 75 33
Generics Pharma Hellas
: +30 210 993 6 sterreich Arcana Arzneimittel GmbH Tel: +43 1 416 2Espa a Mylan Pharmaceuticals, S.L Tel: + 34 900 102 Polska Mylan Healthcare Sp. z o.o. Tel: + 48 22 546 64 France Mylan S.A.S Tel: +33 4 37 25 75 Portugal Mylan, Lda. Tel: + 351 21 412 72 Hrvatska Mylan Hrvatska d.o.o. Tel: +385 1 23 50 Rom nia BGP Products SRL Tel: +40 372 579 Ireland Mylan Ireland Limited Tel: +353 1 8711Slovenija Mylan Healthcare d.o.o. Tel: + 386 1 23 63 sland Icepharma hf S m : +354 540 8Slovensk republika Mylan s.r.o. Tel: +421 2 32 199 Italia Mylan Italia S.r.l. Tel: + 39 02 612 46Suomi/Finland Mylan Finland OY Puh/Tel: +358 20 720 9
Varnavas Hadjipanayis Ltd : +357 2220 7Sverige Mylan AB Tel: + 46 855 522 Latvija Mylan Healthcare SIA Tel: +371 676 055 United Kingdom (Northern Ireland) Mylan IRE Healthcare Limited Tel: +353 18711This leaflet was last revised in
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-47e609a7556335e73540caeda7f501b2
Resource Composition:
Generated Narrative: Composition composition-en-47e609a7556335e73540caeda7f501b2
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/23/1721/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - dapagliflozin
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp47e609a7556335e73540caeda7f501b2
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp47e609a7556335e73540caeda7f501b2
identifier:
http://ema.europa.eu/identifier
/EU/1/23/1721/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Dapagliflozin Viatris 5 mg film-coated tablets
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en